The collaboration between CORONA and Ferring will cater to patients across India
New high-tech facility in Biberach offers attractive workplaces for more than 500 scientists
The data highlight the three drug candidates' potential for clinical development and promising synergistic utilities in new indications
Extends patent protection for Microbion's proprietary inhaled pravibismane for the treatment of pulmonary infections to 2039
The antiviral is efficacious in non-human primates, and is safe and well-tolerated in humans
The one-year-long study was aimed to evaluate the efficacy of LDH's digital therapeutics platform
Dr. Hubbard brings more than 35 years of experience in the biopharmaceutical and pharma-tech services industries and CROs.
Clinical studies are expected to start in Q2 2023.
The safety profile of LAGEVRIO in this trial was generally consistent with that observed in previously reported clinical studies
New subgroup analysis from Phase III ARASENS trial shows that darolutamide plus androgen deprivation therapy (ADT) in combination with docetaxel increased overall survival (OS)
Subscribe To Our Newsletter & Stay Updated
